Birchview Capital, LP - MERRIMACK PHARMACEUTICALS IN ownership

MERRIMACK PHARMACEUTICALS IN's ticker is MACKXXXX and the CUSIP is 590328100. A total of 4 filers reported holding MERRIMACK PHARMACEUTICALS IN in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Birchview Capital, LP ownership history of MERRIMACK PHARMACEUTICALS IN
ValueSharesWeighting
Q2 2017$55,000
-59.6%
44,0000.0%0.03%
-61.8%
Q1 2017$136,000
-24.4%
44,0000.0%0.08%
-31.5%
Q4 2016$180,000
-35.5%
44,0000.0%0.11%
-31.9%
Q3 2016$279,000
+17.7%
44,0000.0%0.16%
-5.2%
Q2 2016$237,000
-35.6%
44,0000.0%0.17%
-34.4%
Q1 2016$368,000
+55.3%
44,000
+46.7%
0.26%
+92.6%
Q4 2015$237,000
-34.2%
30,000
-29.1%
0.14%
-41.4%
Q3 2015$360,000
-31.2%
42,3000.0%0.23%
-15.9%
Q2 2015$523,000
+4.0%
42,3000.0%0.28%
+4.5%
Q1 2015$503,000
+5.2%
42,3000.0%0.26%
-5.0%
Q4 2014$478,00042,3000.28%
Other shareholders

There were no reported owners of MERRIMACK PHARMACEUTICALS IN in Q3 2017.

NameSharesValueWeighting ↓
View complete list of MERRIMACK PHARMACEUTICALS IN shareholders